The Morton Grove Pharmaceuticals was founded in 1990. It’s a U.S.-based private company in the Biotechnology and Pharmaceutical industry. It manufactures liquid, oral, and topical generic drugs. The company makes over 50 products. They include prescription pharmaceuticals like acetaminophen with codeine, fluoxetine, and corticosteroid prednisolone. The company also manufactures over-the-counter liquids. These include Mystussin (Robitussin), a cough remedy, and antihistamine diphenhydramine (Benadryl).
The distribution of Morton Grove Pharmaceuticals is through chain pharmacies, wholesalers, managed care providers, and retailers. Topical lice-control drugs that contain lindane contributes to almost one-third of the company’s sales. Morton Grove Pharmaceuticals location is 6451 Main St, Morton Grove, IL 60053, United States. On weekdays it’s open from 8.00 am-4.00 pm and closes over the weekends.
Acquisition of the Company
Wockhardt Limited, an India-based company, has its headquarters in Mumbai. It has manufacturing plants in the US, France, India, UK, and Ireland. There’re subsidiaries in the U.S., UK, France, and Ireland. Half of this global company’s revenue comes from Europe. Biopharmaceuticals, formulations, vaccines, active pharmaceutical ingredients, and nutrition products are some of Wockhardt’s production. In emerging markets like Brazil, Russia, Mexico, Vietnam, Kenya, Uganda, Sri Lanka, Kuwait, Lebanon, Mauritius, Myanmar, Philippines, Ghana, Nigeria, and Nepal, Wockhardt has a market presence.
On October 24, 2007, Wockhardt acquired Morton Grove Pharmaceuticals. The acquisition of the U.S.-based drug company cost Wockhardt Ltd $38 million. The aim was to strengthen Wockhardt’s presence globally in the largest drug market. Acquiring Morton Grove Pharmaceuticals raised Wockhardt’s U.S. revenue and boosted the product range to 54 in that market. Wockhardt’s position is now stable in the U.K. and U.S. liquid market. Morton Grove acquisition was the third by Wockhardt after Ireland’s Pinewood and France’s Negma.
Morton Grove Pharmaceuticals now runs under the Wockhardt USA. Morton Grove, with 31 products of which 13 were number 1 in the market, provided Wockhardt entry into the generic market in the U.S.
Drugs by Wockhardt USA LLC
The Wockhardt USA makes over 68 drugs and distributes them in the United States. Some of the drugs it manufactures include abiraterone, acetic acid, acetaminophen, alfuzosin, amantadine, amlodipine, amoxicillin/clavulanate, bethanechol, captopril, dexamethasone, lindane, among other drugs. The drug names may differ in other non-US regions.
US FDA Approval
Wockhardt, on August 11, 2017, received US FDA approval for Oxacillin, an antibiotic injection. This antibiotic is penicillinase-resistant that treats various infections caused by Staphylococcal, which is penicillin-resistant. The antibiotic also remedies Urinary Tract Infections, Wound Infection, Bacterial meningitis, Septicemia, Respiratory Tract infections, among others.
More on Wockhardt
Wockhardt happens to be the only company globally to be given (Qualified Infectious Diseases Programme) QIDP status by USFDA. For 5 of its Anti-bacterial discovery, it has 3 Gram Positive and 2 Gram Negative, which are effective against “superbugs” that are untreatable.
Wockhardt employs over 10,000 people from the U.K., USA, France, Russia, Mexico, and other nations. There’re over 600 scientists with more than 70 doctorates. The company also has research and manufacturing and facilities in the U.K., USA, and India. In the US, India, and Europe, Wockhardt’s presence is significant, with global revenue of 61% from international businesses.
